DPP4 and type 2 diabetes mellitus: Treatment with DPP4 inhibitors also reduced sUA levels (5.2±1.3 mg/dL vs. 5.9±2.2mg/dL, p=0.05).Fig. 2displays trendsof eGFR for patients with T2DM and gout treated with DPP-4 inhibitors vs. controlgroup.